Enhertu

Product NDC
65597-406
11-digit product format
655970406
Labeler code
65597
Product ID
65597-406_50272b50-1dd2-49a0-a74e-e6e182decb79
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
fam-trastuzumab deruxtecan-nxki
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Daiichi Sankyo Inc.
Application
BLA761139
Marketing category
BLA
Marketing start
2019-12-20
Substance
TRASTUZUMAB DERUXTECAN
Active strength
100 mg/5mL
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Enhertu
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TRASTUZUMAB DERUXTECAN100 mg/5mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii5384HK7574
Rxcui2267576, 2267581

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
7195b158-8eea-4ef1-aa71-d7f22e2af1c4Product name120200604
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
65597-406-012024-02-05C16284748780-11030e365-11f4-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ENHERTU safely and effectively. See full prescribing information for ENHERTU. ENHERTU ® (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use Initial U.S. Approval: 2019
65597-406-012024-02-05C16284748780-11030e365-11f4-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ENHERTU safely and effectively. See full prescribing information for ENHERTU. ENHERTU ® (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use Initial U.S. Approval: 2019
65597-406-012024-02-05C16284748780-11030e365-11f4-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ENHERTU safely and effectively. See full prescribing information for ENHERTU. ENHERTU ® (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use Initial U.S. Approval: 2019
65597-406-012024-01-30C16284748780-11030e365-11f4-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ENHERTU safely and effectively. See full prescribing information for ENHERTU. ENHERTU ® (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use Initial U.S. Approval: 2019
65597-406-012024-01-30C16284748780-11030e365-11f4-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ENHERTU safely and effectively. See full prescribing information for ENHERTU. ENHERTU ® (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use Initial U.S. Approval: 2019
65597-406-012024-01-30C16284748780-11030e365-11f4-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ENHERTU safely and effectively. See full prescribing information for ENHERTU. ENHERTU ® (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use Initial U.S. Approval: 2019

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65597-406-01Enhertu1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,128
65597-406-01Enhertu5 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,528

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
65597-406-01EA - Each65597-4069bfdad47-da53-43a9-a828-f8407e110abe12020-01-03

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65597-406ENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [DAIICHI SANKYO INC.]21Current NDC, Legacy NDC, 2 package rows20250522_7e67e73e-ddf4-4e4d-8b50-09d7514910b6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2267581ENHERTU 100 MG InjectionPSN7e67e73e-ddf4-4e4d-8b50-09d7514910b628
2267576fam-trastuzumab deruxtecan-nxki 100 MG InjectionPSN7e67e73e-ddf4-4e4d-8b50-09d7514910b628
2267581fam-trastuzumab deruxtecan-nxki 100 MG Injection [Enhertu]SBD7e67e73e-ddf4-4e4d-8b50-09d7514910b628
2267576fam-trastuzumab deruxtecan-nxki 100 MG InjectionSCD7e67e73e-ddf4-4e4d-8b50-09d7514910b628
2267581Enhertu 100 MG InjectionSY7e67e73e-ddf4-4e4d-8b50-09d7514910b628

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
65597-406-01655970406011 VIAL, SINGLE-DOSE in 1 CARTON (65597-406-01) / 5 mL in 1 VIAL, SINGLE-DOSE2019-12-200000-00-00NoNoCurrent